Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

CONSTELLATION PHARMACEUTICALS, INC.

(CNST)
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancials 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Constellation Pharmaceuticals : RBC Capital Downgrades Constellation Pharmaceuticals to Sector Perform From Outperform, Price Target Cut to $34 From $50

06/17/2021 | 08:53am EDT


ę MT Newswires 2021
All news about CONSTELLATION PHARMACEUTICALS, INC.
07/28PRESS RELEASE : MorphoSys AG Reports Second -3-
DJ
07/28PRESS RELEASE : MorphoSys AG Reports Second Quarter and First Half 2021 Results
DJ
07/26DGAP-ADHOC : Ad-hoc: MorphoSys AG to update financial guidance for 2021 and redu..
DJ
07/21PRESS RELEASE : Invitation to MorphoSys' Second Quarter and First Half 2021 Resu..
DJ
07/19MorphoSys Concludes a US$ 100 Million Capital Increase to Implement the Purch..
AQ
07/16MORPHOSYS : Royalty Pharma Takes Equity Position in MorphoSys for $100 Million
MT
07/16MorphoSys AG
AQ
07/16PRESS RELEASE : MorphoSys Concludes a USUSD 100 Million Capital Increase to Impl..
DJ
07/15SECTOR UPDATE : Health Care Stocks Lower Just Ahead of Closing Bell
MT
07/15SECTOR UPDATE : Health Care Stocks Lacking Much Traction
MT
More news
Financials (USD)
Sales 2021 - - -
Net income 2021 - - -
Net Debt 2021 - - -
P/E ratio 2021 -
Yield 2021 -
Capitalization 1 633 M 1 633 M -
Capi. / Sales 2021 -
Capi. / Sales 2022 283x
Nbr of Employees 154
Free-Float 98,7%
Chart CONSTELLATION PHARMACEUTICALS, INC.
Duration : Period :
Constellation Pharmaceuticals, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Managers and Directors
Lara Smith-Weber President, Secretary & Treasurer
Mohan Bala Chief Operating Officer
Kathleen Warnecke Director
Kia Khalaghpour Vice President-Investor Relations & Communications
Brad Prosek Chief Business Officer
Sector and Competitors
1st jan.Capi. (M$)
CONSTELLATION PHARMACEUTICALS, INC.18.02%1 625
GILEAD SCIENCES, INC.17.22%85 723
BIONTECH SE317.33%82 168
WUXI APPTEC CO., LTD.41.52%69 241
REGENERON PHARMACEUTICALS18.94%59 765
VERTEX PHARMACEUTICALS-16.09%51 450